Product Information
SPS 15 GM/60 ML SUSPENSION is a generic product labeled by CMP Pharma, Inc., priced at $0.3851 per ML under NDC 46287000660. Its NADAC has been published 474 times since Nov 28, 2013.
FDA first approved this application on Dec 8, 1982. Its Orange Book therapeutic-equivalence code is AA.
Strength
15 g/60mL
Manufacturer
CMP Pharma, Inc.NDC
46287000660
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL; RECTAL
Effective Date
4/22/2026
Active Ingredients
SODIUM POLYSTYRENE SULFONATEApproval Type
Generic (ANDA)
FDA Application
ANDA087859FDA Approved
12/8/1982
TE Code
AA
On Market Since
12/8/1982
Price Statistics
The NADAC for SPS 15 GM/60 ML SUSPENSION has been published 474 times since Nov 28, 2013, and over the history we have for it it has risen 254.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3851 per ML |
|---|---|
| All-time high | $0.4117 (Dec 11, 2024) |
| All-time low | $0.1024 (Mar 19, 2014) |
| 52-week high | $0.3963 |
| 52-week low | $0.3851 |
| Median price | $0.1308 |
| Average price | $0.2178 |
| Largest weekly change | +167.4% (Jul 19, 2023) |
| Weeks tracked | 474 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
CMP Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sodium polystyrene sulfonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SPS 15 GM/60 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for SPS 15 GM/60 ML SUSPENSION, manufactured by CMP Pharma, Inc., is $0.3851 per ML (NDC 46287000660), effective Sep 30, 2026.
How has the price of SPS 15 GM/60 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for SPS 15 GM/60 ML SUSPENSION has risen 254.2%. It has been tracked across 474 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SPS 15 GM/60 ML SUSPENSION?
Since Nov 28, 2013, the NADAC for SPS 15 GM/60 ML SUSPENSION has ranged from a low of $0.1024 (Mar 19, 2014) to a high of $0.4117 (Dec 11, 2024), with a median of $0.1308 per ML.
Are there cheaper alternatives to SPS 15 GM/60 ML SUSPENSION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SPS 15 GM/60 ML SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures SPS 15 GM/60 ML SUSPENSION?
SPS 15 GM/60 ML SUSPENSION (NDC 46287000660) is labeled by CMP Pharma, Inc., and CMS classifies it as a generic product.